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Loss of retinal ganglion cells (RGCs) has a central role in
retinal disorders including glaucoma, which result in progres-
sive vision loss over time. The global glaucoma prevalence
is currently estimated to be 3.54% of the population aged
between 40 and 80 years.1 Currently, raised intraocular
pressure (IOP) presents the only modifiable risk factor.
However, some glaucoma patients continue to lose vision
despite having well controlled IOPs.2 This has led to a search
for alternative strategies to promote RGC preservation.3
Experimental glaucoma models and whole-retinal mounts
have proven a useful ex vivo tool for the assessment of
potential new treatments using well-established protocols for
labelling RGCs, including using nuclear-restricted transcrip-
tion factor brain-specific homeobox/POU domain protein 3A
(Brn-3A).
Animal models of ocular disease have made an invaluable
contribution to the development of new therapies, dramatically
enhancing the quality of life of people with sight-threatening
diseases.4 Increasing scrutiny of the scientific, ethical and
economic use of procedures involving animals, however, has
resulted in growing pressures ‘to reduce the sum total of pain
and fear inflicted on animals byman’ via the 3R’s approach.2 In
this context, reduction is defined by Russell and Burch’s as a
‘Reduction in the number of animals used to obtain information
of a given amount or precision’.5 Overzealous efforts to
achieve this goal by simply minimising the number of animals
used in experiments (for cost or ethical reasons) can, however,
undermine study reliability and therefore result in unnecessary
distress.6 Although the appropriate use of statistical methods
to assess study power can be used to indicate the minimum
number of animals required to conduct an experiment with the
required power, a lack of preliminary data owing to variability in
the implementation of models or experimental end points can
impede their use.5,7 One solution to this problem is to increase
the amount of useful information extracted from each
laboratory animal used in an experiment.
RGCquantification fromBrn-3A-labelled retinal wholemounts
is frequently achieved by sampling regions for manual counting.
Although this technique provides an improvement on assessing
RGC health from histological cross-sections (where typically as
little as 0.1% of the total RGC population are evaluated), it
remains susceptible to error, both from inter- and intra-operator
variability and variation of RGC density across a retina (i.e., a
threefold difference inRGCdensity is typically reported between
central and peripheral rodent retina). In recent years, the
development of automated whole-retinal measures of RGC
density has sought to overcome limitations of the sampling
approach, typically reducing each whole-retinal mount into a
singlemeanRGCdensity data point.8 As typical healthy adult rat
retina contains between 80 000 and 100 000 RGCs, a large
amount of potentially useful information is discarded by only
reporting changes as a single mean RGC density.
To resolve this problem, we9 describe a simple technique
to extract greater information from RGC populations in retinal
whole mounts in two established rodent models of optic
neuropathy: the partial optic nerve transection (pONT)10 and
Morrison’s ocular hypertension (OHT) models.11 Each of
these models are used to assess secondary degeneration
of RGCs, which is thought to have a role in diseases such
as glaucoma. Improving our understanding of the spatial-
temporal pattern of RGC loss using these models can be used
to provide useful insights regarding the disease mechanism
and the activity of therapeutic interventions (Figure 1).
Using this technique, we demonstrate the spatiotemporal
pattern of RGC loss in each model to a greater resolution than
that has previously been achieved by dividing the retinal area
into a series of 60 nonoverlapping segments from which RGC
density, nearest neighbour distance and regularity index were
calculated. In addition, by monitoring the longitudinal rate of
RGC loss in each model, the proportion of primary and
secondary degeneration in each retinal segment could be
estimated. To evaluate the validity of this approach, the
technique was first used to investigate the extent of RGC
density loss and the distribution of primary and secondary
degeneration events in pONT. Results obtained using our
technique were in broad agreement with the existing literature
with a greater proportion of primary degeneration and RGC
loss reported in the superior retinal quadrant.12 The technique
was next applied to the less well-described OHT model. The
greatest loss of RGCs was observed along the superior-
inferior axis, a result which shows a striking similarity to the
bow-tie pattern of retinal nerve fibre layer injury reported
in clinical glaucoma patients.13 This is a surprising result
as the rat possesses a relatively simple lamina cribrosa
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structure relative to humans, which has been suggested to be
responsible for this pattern of cell loss.13,14 Having established
the natural history of pONT and OHT models, this study
provides sufficient preliminary data to calculate the statistical
power of future studies aimed at investigating the efficacy of
therapeutic interventions.
The retina offers the unique opportunity to non-invasively
image structures of the central nervous system and comprises
a well-established anatomy and simple structure compared to
the brain. This, combined with the growing recognition that
the retina also undergoes marked changes in neurodegenera-
tive disorders makes retinal analysis an attractive tool to
investigate neurodegenerative processes.15 A better under-
standing of ocular changes during neurodegenerative dis-
eases is anticipated to yield novel early diagnostic techniques
for disorders such as Alzheimer’s Disease, which are urgently
required.15 To this end, the analysis techniques described
in this work with RGCs can readily be combined with
well-established specific markers for other anatomic features
including; glial, vasculature and retinal barrier function in
order to provide a surrogate method to evaluate cellular
pathology of neurodegenerative disease in the brain. This is
significant as not only could this facilitate the development
of novel diagnostic tests for neurodegenerative disease, but
could also enhance our understanding of the mechanism
of neurodegenerative disease progression and provide amuch
needed time frame for early changes in the disease process.
In summary, the development of techniques such as those
described by our recent paper contribute to a growing body of
work that seeks to maximise the amount of information that
can be extracted from each laboratory animal and provide
tools to increase the uniformity of techniques employed by
groups using animals in research.
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Figure 1 Maximising the extraction of information from retinal whole-mounts. (a) Brn-3a retinal whole-mounts were obtained at different timeponts from established rodent
models of optic neuropathy. (b) The algorithm we developed9 first segmented the RGC population from these whole-mounts before spatially segmenting the population into a
series 60 of non-overlapping sectors defined relative to the position of the optic nerve head. (c) Assessment of longitudinal changes across the natural history of each model
permitted the spatial-patterns in RGC density changes, half-life and the extent of primary degeneration to be evaluated and summarised as colourmaps
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